You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model

Article metrics

Article menu

Download PDFPDF

Research Article
Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model

 

Online download statistics by month:

Online download statistics by month: January 2020 to July 2025

AbstractFullPdf
Jan 2020772
Feb 2020661
Mar 202024242
Apr 202010101
May 202020208
Jun 202014144
Jul 202012123
Aug 2020990
Sep 202020204
Oct 20201581586
Nov 202014145
Dec 202017173
Jan 2021993
Feb 202120203
Mar 202120180
Apr 202118182
May 202112121
Jun 202129291
Jul 2021262610
Aug 2021991
Sep 202119194
Oct 202121215
Nov 202113125
Dec 202125252
Jan 202221244
Feb 202221215
Mar 202216187
Apr 202216174
May 202224244
Jun 202223230
Jul 202215162
Aug 202231316
Sep 202229312
Oct 202224254
Nov 2022252710
Dec 202211112
Jan 202317171
Feb 202333333
Mar 202325256
Apr 2023202211
May 20238113
Jun 202315153
Jul 202321219
Aug 2023773
Sep 2023881
Oct 202317173
Nov 202313131
Dec 202343435
Jan 202429302
Feb 202437376
Mar 202423247
Apr 2024252510
May 202437374
Jun 202469685
Jul 2024464715
Aug 2024373410
Sep 2024222211
Oct 2024282813
Nov 202421228
Dec 202441416
Jan 202535358
Feb 202539395
Mar 2025313110
Apr 2025515414
May 2025252511
Jun 202530319
Jul 2025110
Total16421660329